Trials / Unknown
UnknownNCT03668158
Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish molecular subtyping of HCC.
Detailed description
Hepatocellular carcinoma is one of the most common malignant tumors in the world with high incidence and mortality. Liver transplantation is the most effective treatment for HCC and is in high demand in China. However, recurrence of HCC among liver transplantation recipients is still a great challenge and threat to the survival of recipients. So it is of great significance to establish molecular subtyping of HCC and achieve precise selection of recipients. Based on large scales of samples, the investigator's study aims to establish multi-omics characteristic profiles of liver transplantation for HCC in integration of apparent biological characteristics, clinical management and prognostic information by utilizing genomics, transcriptomics and proteomics, etc. This study will contribute to the therapy-oriented molecular subtyping of HCC.
Conditions
Timeline
- Start date
- 2018-11-20
- Primary completion
- 2020-05-01
- Completion
- 2020-07-01
- First posted
- 2018-09-12
- Last updated
- 2018-10-24
Source: ClinicalTrials.gov record NCT03668158. Inclusion in this directory is not an endorsement.